Lam Research Corporation $LRCX Holdings Trimmed by Simon Quick Advisors LLC

Simon Quick Advisors LLC cut its holdings in Lam Research Corporation (NASDAQ:LRCX) by 85.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,302 shares of the semiconductor company’s stock after selling 13,428 shares during the quarter. Simon Quick Advisors LLC’s holdings in Lam Research were worth $308,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. IMG Wealth Management Inc. bought a new stake in shares of Lam Research in the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new position in Lam Research in the second quarter worth approximately $27,000. Sound Income Strategies LLC bought a new position in shares of Lam Research in the third quarter valued at $41,000. Tripletail Wealth Management LLC acquired a new stake in shares of Lam Research during the 3rd quarter valued at $44,000. Finally, Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research during the 2nd quarter worth $29,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Lam Research

In other news, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president directly owned 251,047 shares in the company, valued at $34,870,428.30. The trade was a 17.21% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. The trade was a 3.90% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 102,608 shares of company stock valued at $14,916,496 over the last 90 days. Company insiders own 0.31% of the company’s stock.

Lam Research Stock Performance

LRCX stock opened at $185.06 on Monday. The stock has a market cap of $232.44 billion, a P/E ratio of 40.76, a P/E/G ratio of 2.14 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The firm has a 50 day simple moving average of $161.34 and a 200 day simple moving average of $129.39. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $185.78.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. During the same quarter last year, the business posted $0.86 EPS. The company’s revenue for the quarter was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be given a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research’s dividend payout ratio is presently 22.91%.

Analyst Upgrades and Downgrades

LRCX has been the topic of a number of recent analyst reports. TD Cowen boosted their target price on Lam Research from $145.00 to $170.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Evercore ISI boosted their price objective on Lam Research from $115.00 to $170.00 and gave the stock an “outperform” rating in a report on Thursday, October 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $210.00 price objective on shares of Lam Research in a research note on Tuesday, December 16th. Berenberg Bank lifted their target price on shares of Lam Research from $122.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Finally, Wells Fargo & Company boosted their price target on shares of Lam Research from $135.00 to $145.00 and gave the company an “equal weight” rating in a report on Thursday, October 23rd. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $161.21.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.